Explore

Rapid Read Rapid Read
New Single-Cell Platform Enhances Understanding of Immune Cell Behavior

New Single-Cell Platform Enhances Understanding of Immune Cell Behavior

Researchers have developed a new single-cell sequencing method called CIPHER-seq, which allows for the simultaneous measurement of RNA and proteins within the same immune cell. This platform provides a more comprehensive view of immune cell behavior by capturing both genetic intent and functional output. Developed by the Sylvester Comprehensive Cancer Center and collaborators, CIPHER-seq addresses the gap between RNA levels and actual protein production, particularly in cytokine signaling. The method has been validated by tracking immune cell responses, revealing the timing of RNA and protein production and offering insights into immune activity.
Rapid Read Rapid Read
Researchers Develop CIPHER-seq for Enhanced Immune Cell Profiling

Researchers Develop CIPHER-seq for Enhanced Immune Cell Profiling

Researchers have developed CIPHER-seq, a new single-cell platform that tracks both RNA and protein in immune signaling, providing a more complete snapshot of immune activity than RNA-only approaches. This method, developed by researchers at the University of Miami Miller School of Medicine, captures multiple molecular layers simultaneously within single immune cells, bridging the gap between genetic intent and functional output. The technology was benchmarked using peripheral blood mononuclear cells (PBMCs) from a healthy donor, focusing on RNA integrity, mitochondrial transcript enrichment, and RNA-protein coordination. The study highlights the improved correlation coefficients achieved with CIPHER-seq compared to external datasets, despite the inherent RNA-protein discordance due to biological phenomena such as post-transcriptional regulation and protein stability.
Trendline Trendline
Westlake University Develops High-Throughput Platform for Covalent Protein Therapies with Implications for Cancer and Antiviral Treatments

Westlake University Develops High-Throughput Platform for Covalent Protein Therapies with Implications for Cancer and Antiviral Treatments

Westlake University Develops High-Throughput Platform for Covalent Protein Therapies with Implications for Cancer and Antiviral Treatments
Rapid Read Rapid Read
CRISPR Activation Screens Reveal RNA-Based Mechanisms to Enhance Cancer Cell Sensitivity to T Cell Therapy

CRISPR Activation Screens Reveal RNA-Based Mechanisms to Enhance Cancer Cell Sensitivity to T Cell Therapy

A study conducted at Stanford University has utilized high-content CRISPR activation screens to identify RNA-based mechanisms that can make cancer cells more susceptible to targeted T cell cytotoxicity. The research involved using CRISPR technology to activate specific genes in cancer cells, thereby sensitizing them to T cell attacks. The study focused on melanoma and breast adenocarcinoma cell lines, using engineered T cells to target cancer-specific antigens. The findings suggest that certain RNA pathways can be manipulated to enhance the effectiveness of T cell therapies, offering a potential new avenue for cancer treatment.
Rapid Read Rapid Read
St. Jude Researchers Enhance Immunotherapy by Boosting Dendritic Cell Mitochondria

St. Jude Researchers Enhance Immunotherapy by Boosting Dendritic Cell Mitochondria

A study from St. Jude Children’s Research Hospital has revealed a new method to enhance cancer immunotherapy by restoring mitochondrial function in dendritic cells. Published in Science, the research shows that tumors impair dendritic cells' ability to activate the immune system by reducing their mitochondrial activity. By boosting this activity, researchers were able to restore the cells' function and improve antitumor immunity. In preclinical models, combining enhanced dendritic cells with immune checkpoint blockade significantly slowed tumor growth and extended survival. This approach also demonstrated long-term immune memory, preventing new tumor growth in treated mice.
Rapid Read Rapid Read
Global Alliance for Spatial Technologies Promotes Development of Spatial Biology Techniques

Global Alliance for Spatial Technologies Promotes Development of Spatial Biology Techniques

The Global Alliance for Spatial Technologies is actively working to accelerate the development and application of spatially resolved technologies in biomedical research. This initiative aims to integrate single-cell data with spatial context to provide comprehensive insights into biological and clinical questions. Jasmine Plummer, the founding Director of the Center for Spatial Omics at St. Jude Children’s Research Hospital, is at the forefront of this effort, developing cutting-edge spatial genomics and multiomics technologies. These techniques are crucial for mapping cellular interactions within intact tissues, which can lead to a better understanding of cancer and neurodevelopmental diseases. The alliance seeks to foster collaboration among researchers, clinicians, and technologists to build shared standards and lower barriers to using these powerful tools.
Rapid Read Rapid Read
TGH Cancer Institute Hosts International Symposium on Microbes, Genes, and Cancer

TGH Cancer Institute Hosts International Symposium on Microbes, Genes, and Cancer

The Tampa General Hospital (TGH) Cancer Institute, in collaboration with the USF Health Morsani College of Medicine and the Global Virus Network, hosted the 'Microbes, Genes & Cancer' Symposium in Tampa. This event brought together international leaders in oncology, virology, and immunology to discuss the intersection of microbes, genetics, and immune pathways in cancer development and treatment. The symposium also marked the 50th anniversary of the discovery of Interleukin-2 (IL-2), a pivotal breakthrough in cancer immunotherapy. The event highlighted Tampa General's growing influence in cancer research and its ability to convene leading scientific minds to foster collaboration and innovation.
Rapid Read Rapid Read
St. Jude Researchers Enhance Immunotherapy by Restoring Mitochondrial Function in Dendritic Cells

St. Jude Researchers Enhance Immunotherapy by Restoring Mitochondrial Function in Dendritic Cells

Researchers at St. Jude Children’s Research Hospital have discovered a new metabolic mechanism that tumors use to disable dendritic cells, which are crucial for initiating an immune response against cancer. The study, published in Science, reveals that tumors impair dendritic cell function by reducing mitochondrial fitness, thereby weakening the immune system's ability to fight cancer. By enhancing mitochondrial function in these cells, the researchers were able to restore their activity and improve the efficacy of existing immunotherapies. In preclinical mouse models, introducing dendritic cells with high mitochondrial activity into tumors restored immunogenic activity and improved tumor control.
Trendline Trendline
AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research

AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research

AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research
Rapid Read Rapid Read
Nanotube Injector Enhances Mitochondrial Function for Regenerative Medicine

Nanotube Injector Enhances Mitochondrial Function for Regenerative Medicine

Researchers from Waseda University in Japan have developed a nanotube injector that significantly boosts mitochondrial performance through cytoplasmic transfer. This innovative system uses a thin gold membrane with vertically aligned nanotubes to transfer cytoplasmic contents, including mitochondria, between cell populations without damaging the cells. The nanotube injector allows for controlled and efficient cytoplasmic transfer, maintaining high cell viability and transfer efficiency. The technology is particularly relevant for regenerative medicine, where therapeutic cells often suffer from reduced metabolic activity. By enhancing mitochondrial function without genetic modification, the nanotube injector offers a new strategy to improve cell quality prior to transplantation.
Trendline Trendline
Anixa Biosciences Advances Cancer Immunotherapy with New Clinical Trials

Anixa Biosciences Advances Cancer Immunotherapy with New Clinical Trials

Anixa Biosciences Advances Cancer Immunotherapy with New Clinical Trials
Trendline Trendline
Waseda University Develops Nanotube Injector to Enhance Mitochondrial Function in Cells

Waseda University Develops Nanotube Injector to Enhance Mitochondrial Function in Cells

Waseda University Develops Nanotube Injector to Enhance Mitochondrial Function in Cells